A Novel Activation-Induced Cytidine Deaminase (AID) Mutation in an Adult with Hyper-IgM Syndrome (HIMS)
Abstract
The hyper-immunoglobulin M (HIGM) syndromes are a group of immunodeficiencies that exhibit low or absent levels of immunoglobulin G (IgG), immunoglobulin A (IgA), immunoglobulin E (IgE), and normal to high levels of immunoglublin M (IgM) [1]. These syndromes are characterized by inherited defects in genes encoding for the CD40L or CD40 molecule, or defects in class-switch recombination (CSR) in B cells [2]. Activation-induced cytidine deaminase (AID) is a protein that is required for CSR in B cell differentiation [3,5]. A mutation in the activation-induced cytidine deaminase (AICDA) gene that encodes AID, causes the autosomal recessive (AR) form of HIGM syndrome known as HIGM2 [2,4]. This syndrome results in recurrent sinopulmonary infections by encapsulated bacteria, meningitis, gastrointestinal infections, lymphoid hyperplasia, and autoimmune conditions [2]. We report a case of a novel autosomal dominant (AD) mutation in the AID gene that has not been previously reported.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2020
- Accession Number
- AD1111283
Entities
People
- Anthony Infante
- James Quinn
- Jun Mendoza
- Nutchaya Amornruk
- Priya Nath
Organizations
- 59th Medical Wing